From Trial to Practice–Integrating the Latest Evidence Into the Treatment of EGFR-Mutated NSCLC

Advance your approach to EGFR-mutant NSCLC—get up to speed on the latest clinical trial data and evolving treatment strategies.🧬 In this free, on-demand activity, you’ll interpret new safety and efficacy data, apply guideline-driven approaches to build personalized first-line treatment plans, and refine your management of EGFR therapy–related adverse events. 🚀Start learning now: https://bit.ly/4uFw7HG